Skip to content
Home/Companies/MedTech/BOYDSense
BOYDSense

BOYDSense

MedTech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns BOYDSense?

BOYDSense is a French MedTech company, currently owned by Jolt Capital since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Jolt Capital
Investor
Jolt Capital
Jolt Capital IV · 2021 · Growth

Key facts

SectorMedTech
Websiteboydsense.com

More from Jolt Capital IV

Other portfolio companies in the same fund.

ChapsVision
ChapsVision
Active
SoftwareFrance· 2024
Dolphin Semiconductor
Dolphin Semiconductor
Active
TMTFrance· 2024
BIOSERENITY
Bioserenity
Active
MedTechFrance· 2023
EVUM Motors
Exited 2025
MobilityGermany· 2023
to EVUM Motors s.r.o.
MICROOLED
Microoled
Active
Deep TechFrance· 2023
BC Platforms
BC Platforms
Active
HealthTechSwitzerland· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns BOYDSense?

BOYDSense is currently owned by Jolt Capital, through Jolt Capital IV, since 2023.

When did Jolt Capital acquire BOYDSense?

Jolt Capital acquired BOYDSense in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue